Name: Rein Therapeutics Inc. (RNTX) Balance Sheet
Creator: FinSpry

Rein Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Rein Therapeutics Inc. (RNTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	12.87	17.31	5.19	45.93	7.05	18.30	20.70
Short-Term Investments	0.00	0.00	16.05	42.33	6.76	0.00	0.00
Cash & Short-Term Investments	12.87	17.31	21.24	45.93	13.81	18.30	20.70
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.68	0.72	0.61	2.22	1.93	0.00	0.00
Total Current Assets	13.66	18.27	21.87	48.18	16.33	19.55	21.78
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.02	0.11	0.28	0.02	6.36	7.29
Goodwill	6.33	6.33	0.00	0.00	0.00	0.00	0.00
Intangible Assets	42.20	79.20	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.05	0.02	0.02	0.00	0.57	1.25
Total Non-Current Assets	48.53	87.74	0.13	0.30	0.02	6.92	8.54
Total Assets	62.19	106.01	22.01	48.48	16.34	26.47	30.31
Current Liabilities
Accounts Payable	0.91	1.19	1.72	4.42	1.60	5.39	5.37
Short-Term Debt	0.00	0.00	0.00	0.00	0.17	0.00	0.00
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.00	0.17	0.00	0.00
Accrued Liabilities	4.72	2.94	1.45	3.15	1.95	0.00	0.00
Other Current Liabilities	0.12	0.21	0.18	1.18	0.24	0.00	0.42
Total Current Liabilities	5.75	4.39	3.38	4.51	3.96	5.84	5.37
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.07	0.22	4.59	5.34
Deferred Tax Liabilities	1.77	3.33	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.28	0.00	0.00	0.00	0.17	0.00	0.00
Total Non-Current Liabilities	47.05	94.74	0.00	0.07	0.39	4.59	5.34
Total Liabilities	52.80	99.12	3.38	4.58	4.18	10.43	10.71
Stockholders' Equity
Common Stock	0.11	0.09	0.09	0.09	0.04	0.00	0.00
Retained Earnings	-351.40	-288.52	-272.79	-245.47	-219.29	-198.14	-168.49
Accumulated Other Comprehensive Income	-0.02	-0.06	-0.05	-0.01	0.00	0.01	0.00
Additional Paid-in Capital	360.70	295.38	291.37	289.28	231.41	214.15	188.08
Shares Outstanding	21.67	4.89	4.54	4.53	0.00	0.00	0.00
Total Stockholders' Equity	9.39	6.89	18.62	43.90	12.16	16.05	19.60
Total Liabilities & Equity	62.19	106.01	22.01	48.48	16.34	26.47	30.31